31 March 2014Kate Alzapiedi

Copyright compliance in the life sciences industry

Now that the rapid exchange of scientific research and product information across international borders has become commonplace, rights holders and users of published material face an increasingly complex set of issues involving reuse rights, permissions, restrictions and fees.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Will Mounjaro and Zepbound get their first US generic rival?

30 June 2026 Sandoz has filed FDA applications for generic versions of Eli Lilly’s blockbuster drugs, marking an early step towards potential competition in the fast-growing GLP-1 market.

Careers

King & Spalding continues hiring spree from pre-merged Winston

30 June 2026 The latest additions bring experience representing technology and medical device companies in complex patent and commercial disputes, with the firm extending its run of bringing in partners from Winston & Strawn before its merger.

Careers

Ashurst Perkins Coie opens its doors following landmark merger

29 June 2026 The newly combined transatlantic firm brings together more than 950 partners across 20 countries, uniting leading patent, trade secrets, life sciences, and tech practices.

More features

‘Blatant imitation’: Indian court blocks copycat pharma branding

Kirkland & Ellis adds leading barrister in London

Kilpatrick adds tech patent litigator and China expert to Chicago office

Litigator from Brown Rudnick moves firms to chair practice

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

Six Summit takeaways: In-person IP, agentic AI and ‘infollution’ risks

Arnold & Porter adds tech litigator in San Francisco

Copyright compliance in the life sciences industry

More on this story

Editor's picks

Editor's picks

More features